Paper6961950
Regulation of human natural killing by levamisole.
Shau H and 1 other. Cancer Immunol Immunother, 1982. Cited by 5 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Regulation of human natural killing by levamisole. Papers, record 6961950. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6961950
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytotoxicity, Immunologic | Major topic |
| Leukemia, Myeloid, Acute | Major topic |
| Levamisole | Major topic |
| Lymphocytes | Major topic |
| Cell Line | |
| Cell Survival | |
| Humans | |
| Kinetics | |
| Leukocytes | |
| Lymphocyte Activation |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA 13070 | NCI NIH HHS | United States | R01CA013070 | PubMed and NIH | NIH RePORTER |
| CA 14049 | NCI NIH HHS | United States | R01CA014049 | PubMed and NIH | NIH RePORTER |
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6166701 | Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. | J Exp Med | 1981 | https://conductscience.org/library/papers/6166701 | PubMed |
| 2 | 173469 | Effects of levamisole and imidazole on lymphocyte proliferation and cyclic nucleotide levels. | Cell Immunol | 1975 | https://conductscience.org/library/papers/173469 | PubMed |
| 3 | 4585358 | Letter: Levamisole and the immune response. | N Engl J Med | 1973 | https://conductscience.org/library/papers/4585358 | PubMed |
| 4 | 55529 | Levamisole in advanced human breast cancer. | Lancet | 1976 | https://conductscience.org/library/papers/55529 | PubMed |
| 5 | 436929 | High nonspecific reactivity of normal lymphocytes against mycoplasma-infected target cells in cytotoxicity assays. | Eur J Immunol | 1979 | https://conductscience.org/library/papers/436929 | PubMed |
| 6 | 36225 | Inhibition of in vitro lymphocyte function by cystic and ascitic fluids from ovarian cancer patients. | Cancer Res | 1979 | https://conductscience.org/library/papers/36225 | PubMed |
| 7 | 6163551 | Interferon induction and augmentation of natural-killer activity by Staphylococcus protein A. | Cell Immunol | 1981 | https://conductscience.org/library/papers/6163551 | PubMed |
| 8 | 6165008 | Influence of anti-mouse interferon serum on the growth and metastasis of tumor cells persistently infected with virus and of human prostatic tumors in athymic nude mice. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6165008 | PubMed |
| 9 | 540153 | [Effect of levamisole on the cytotoxic activity of normal lymphocytes in tissue culture]. | Biull Eksp Biol Med | 1979 | https://conductscience.org/library/papers/540153 | PubMed |
| 10 | 7195412 | Mycoplasma contamination in human tumor cell lines: effect on interferon induction and susceptibility to natural killing. | J Immunol | 1981 | https://conductscience.org/library/papers/7195412 | PubMed |
| 11 | 1222761 | Allogeneic tumor enhancement by levamisole, a new immunostimulatory compound: studies on cell-mediated immunity and humoral antibody response. | Eur J Cancer (1965) | 1975 | https://conductscience.org/library/papers/1222761 | PubMed |
| 12 | 7240748 | In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. | J Immunol | 1981 | https://conductscience.org/library/papers/7240748 | PubMed |
| 13 | 1098727 | Immunopotentiation with levamisole in resectable bronchogenic carcinoma: a double-blind controlled trial; Study Group for Bronchogenic Carcinoma. | Br Med J | 1975 | https://conductscience.org/library/papers/1098727 | PubMed |
| 14 | 150448 | Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells. | J Immunol | 1978 | https://conductscience.org/library/papers/150448 | PubMed |
| 15 | 1206735 | Effects of levamisole on in vivo and in vitro murine host response to syngeneic transplantable tumor. | J Natl Cancer Inst | 1975 | https://conductscience.org/library/papers/1206735 | PubMed |
| 16 | 4718515 | Drug-induced restoration of cutaneous delayed hypersensitivity in anergic patients with cancer. | N Engl J Med | 1973 | https://conductscience.org/library/papers/4718515 | PubMed |
| 17 | 6970103 | Delineation of an effector population responsible for natural killing and antibody-dependent cellular cytotoxicity in man. | Clin Immunol Immunopathol | 1981 | https://conductscience.org/library/papers/6970103 | PubMed |
| 18 | 292811 | Differences in resistance of metastatic tumor cells and cells from local tumor growth to cytotoxicity of natural killer cells. | J Natl Cancer Inst | 1979 | https://conductscience.org/library/papers/292811 | PubMed |
| 19 | 367948 | Do natural killer cells engage in regulated reactions against self to ensure homeostasis? | Immunol Rev | 1979 | https://conductscience.org/library/papers/367948 | PubMed |
| 20 | 6157727 | Spontaneous cytoxicity against virus-infected cells: cellular immunoadsorption on infected cell monolayers. | J Immunol | 1980 | https://conductscience.org/library/papers/6157727 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6573908 | Human natural killing against ovarian carcinoma. | Br J Cancer | 1983 | https://conductscience.org/library/papers/6573908 | PubMed |
| 6500627 | The role of the lysosome in natural killing: inhibition by lysosomotropic vital dyes. | Immunology | 1984 | https://conductscience.org/library/papers/6500627 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6961950
GET https://conductscience.org/api/papers/v1/6961950/authors